Kura Oncology will hold an investor webcast on Oct. 13 to discuss the launch of Caspian Therapeutics and new preclinical data for KO-7246, underscoring its pipeline expansion. Caspian is focused on menin inhibitors for diabetes and cardiometabolic disease.
published
Kura Oncology will hold an investor webcast on Oct. 13 to discuss the launch of Caspian Therapeutics and new preclinical data for KO-7246, underscoring its pipeline expansion. Caspian is focused on menin inhibitors for diabetes and cardiometabolic disease.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.